Search
Quince Therapeutics Inc
QNCXAdd to Watchlist
0.919USD
+0.016+1.73%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.27MMarket Cap
0.04P/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
3
analysts
Hold
Current Rating
80.000
Target Price
+8492.91%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Quince Therapeutics Inc
QNCX
3
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
25
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Quince Therapeutics Inc's price target?
Analysts forecast that Quince Therapeutics Inc's price target is USD 8.00, with the highest forecast at USD 10.00 and the lowest forecast at USD 4.00.
How have Quince Therapeutics IncQNCX's recent earnings per share performed?
The market expectation was USD 36.00, while Quince Therapeutics IncQNCX's earnings per share (EPS) for the previous quarter was USD -7.09. EPS for the next quarter is expected at USD -2.63.
What is the analyst rating for Quince Therapeutics Inc?
Based on the ratings of Quince Therapeutics Inc's stock from 3 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
